TMEM188 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.002210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.306000E-02
Normal-vs-Stage2
1.113380E-01
Normal-vs-Stage3
2.395600E-02
Normal-vs-Stage4
4.738600E-01
Stage1-vs-Stage2
3.086000E-01
Stage1-vs-Stage3
6.802600E-01
Stage1-vs-Stage4
2.833800E-01
Stage2-vs-Stage3
2.100600E-01
Stage2-vs-Stage4
5.322200E-01
Stage3-vs-Stage4
2.389400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.734400E-02
Normal-vs-AfricanAmerican
2.915200E-01
Normal-vs-Asian
7.265500E-02
Caucasian-vs-AfricanAmerican
6.358800E-01
Caucasian-vs-Asian
3.228000E-01
AfricanAmerican-vs-Asian
3.924400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.037450E-01
Normal-vs-Female
1.035160E-01
Male-vs-Female
2.688000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.488300E-02
Normal-vs-Age(41-60Yrs)
2.969200E-01
Normal-vs-Age(61-80Yrs)
6.544400E-02
Normal-vs-Age(81-100Yrs)
1.270130E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.039600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.487200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.144400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.776800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.339920E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.438000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.692100E-02
Normal-vs-Daily Drinker
2.872500E-02
Normal-vs-Weekly Drinker
9.734000E-02
Normal-vs-Occasional Drinker
2.053000E-01
Normal-vs-Social Drinker
2.280200E-01
Non Drinker-vs-Daily Drinker
9.063200E-01
Non Drinker-vs-Weekly Drinker
3.089000E-01
Non Drinker-vs-Occasional Drinker
5.892000E-02
Non Drinker-vs-Social Drinker
6.643800E-02
Daily Drinker-vs-Weekly Drinker
2.914600E-01
Daily Drinker-vs-Occasional Drinker
6.262300E-02
Daily Drinker-vs-Social Drinker
6.983800E-02
Weekly Drinker-vs-Occasional Drinker
4.847400E-01
Weekly Drinker-vs-Social Drinker
4.719800E-01
Occasional Drinker-vs-Social Drinker
9.544800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.867200E-01
Normal-vs-Grade 2
5.843200E-01
Normal-vs-Grade 3
1.215420E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.465600E-01
Grade 1-vs-Grade 3
2.122600E-01
Grade 1-vs-Grade 4
2.867200E-01
Grade 2-vs-Grade 3
7.454800E-01
Grade 2-vs-Grade 4
5.843200E-01
Grade 3-vs-Grade 4
1.215420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.195800E-02
Normal-vs-NonDiabetic
8.112100E-02
Diabetic-vs-NonDiabetic
2.617800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.639510E-03
Normal-vs-NoPancreatitis
8.682200E-02
Pancreatitis-vs-NoPancreatitis
8.700200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.855500E-02
Normal-vs-N1
1.193650E-01
N0-vs-N1
2.793800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.422000E-02
Normal-vs-TP53-NonMutant
4.810200E-02
TP53-Mutant-vs-TP53-NonMutant
4.850800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
